SAFRANEK JOHN 13D and 13G filings for RespireRx Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-22 1:09 pm Purchase |
2021-03-01 | 13G | RespireRx Pharmaceuticals Inc. RSPI |
SAFRANEK JOHN | 4,321,559 5.390% |
4,321,559 (New Position) |
Filing |